ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's clinical stage product candidates include (1) rinzimetostat (ORIC-944), an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.The Director/Senior Director, Business Development, is a strategic leader responsible for driving growth, forging key partnerships, and advancing the company's oncology pipeline. This broad role requires experience in oncology drug development, strong scientific and commercial acumen, and the ability to influence at all levels both internally and externally. The Director/Senior Director, Business Development, will report directly to ORIC's Chief Business Officer and be involved in all aspects of business development, including competitive intelligence, alliance management, search and evaluation, in-licensing, out-licensing, and commercial assessments. The Director/Senior Director, Business Development, is expected to work collaboratively across functions within the organization, represent ORIC to external partners, and play a pivotal role in executing our corporate strategy and mission in oncology.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
101-250 employees